{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:00Z","timestamp":1787002800915,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZW184\/6-1"],"award-info":[{"award-number":["ZW184\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["10001220"],"award-info":[{"award-number":["10001220"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01HG007942"],"award-info":[{"award-number":["U01HG007942"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U2CNS132415"],"award-info":[{"award-number":["U2CNS132415"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS134356"],"award-info":[{"award-number":["U01NS134356"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Serine\/arginine repetitive matrix protein 1 (SRRM1) is a key component of spliceosomes and plays various roles in messenger RNA processing. To date, its function in the nervous system has not been elucidated, and germline variants in\n                    <jats:italic>SRRM1<\/jats:italic>\n                    have not yet been implicated in disease. Through international collaboration, we have identified three individuals harbouring heterozygous truncating variants in\n                    <jats:italic>SRRM1<\/jats:italic>\n                    , presenting variably with developmental delay, intellectual disability, short stature, behavioural and skeletal anomalies, and facial dysmorphism. Two of the variants occurred de novo, while the third could not be tested in the parents. Reduction of SRRM1 to 50% in SKNBE2 cells by introducing a truncating variant via CRISPR-Cas9 editing, followed by differentiation into neuron-like cells, resulted in impaired cell proliferation, migration, and neurite outgrowth compared to wild-type cells. Additionally, the role of\n                    <jats:italic>SRRM1<\/jats:italic>\n                    in nervous system development and functioning was investigated in vivo using a\n                    <jats:italic>Drosophila<\/jats:italic>\n                    model. Pan-neuronal knockdown of the orthologue\n                    <jats:italic>Srrm1<\/jats:italic>\n                    led to reduced viability, while motoneuronal knockdown impaired gross neurological function. Taken together, we provide multiple lines of evidence that loss of\n                    <jats:italic>SRRM1<\/jats:italic>\n                    is associated with nervous system-related phenotypes, and that its haploinsufficiency may be causative for a neurodevelopmental disorder.\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01966-y","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:33:47Z","timestamp":1761543227000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Heterozygous loss of SRRM1 may be associated with neurodevelopmental phenotypes and anomalies in cell growth and neurite morphology"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-5631","authenticated-orcid":false,"given":"Melek Firat","family":"Altay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Rieubland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-1759","authenticated-orcid":false,"given":"Matthias","family":"Gautschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Perret Hoign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rike","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Keren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Afenjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Undiagnosed Diseases Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A.","family":"Martinez-Agosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5664-7987","authenticated-orcid":false,"given":"Jill A.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-2020","authenticated-orcid":false,"given":"Christiane","family":"Zweier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"1966_CR1","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gad.12.7.996","volume":"12","author":"B Blencowe","year":"1998","unstructured":"Blencowe B, Issner R, Nickerson JA, Sharp PA. A coactivator of pre-mRNA splicing. Genes Dev. 1998;12:996\u20131009.","journal-title":"Genes Dev"},{"key":"1966_CR2","doi-asserted-by":"crossref","unstructured":"Will CL, Luehrmann R. Spliceosome Structure and Function. Cold Spring Harb Perspect Biol. 2011;3:a003707.","DOI":"10.1101\/cshperspect.a003707"},{"key":"1966_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","volume":"136","author":"MC Wahl","year":"2009","unstructured":"Wahl MC, Will CL, Luehrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136:701\u201318.","journal-title":"Cell"},{"key":"1966_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1101\/gad.1060403","volume":"17","author":"BR Szymczyna","year":"2003","unstructured":"Szymczyna BR, Bowman J, McCracken S, Pineda-Lucena A, Lu Y, Cox B, et al. Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-mRNA processing. Genes Dev. 2003;17:461\u201375.","journal-title":"Genes Dev"},{"key":"1966_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1017\/S1355838200991982","volume":"6","author":"BJ Blencowe","year":"2000","unstructured":"Blencowe BJ, Baur\u00e9n G, Eldridge AG, Issner R, Nickerson JA, Rosonina E, et al. The SRm160\/300 splicing coactivator subunits. RNA. 2000;6:111\u201320.","journal-title":"RNA"},{"key":"1966_CR6","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0960-9822(01)00589-9","volume":"11","author":"D Longman","year":"2001","unstructured":"Longman D, McGarvey T, McCracken S, Johnstone IL, Blencowe BJ, C\u00e1ceres JF. Multiple interactions between SRm160 and SR family proteins in enhancer-dependent splicing and development of C. elegans. Curr Biol. 2001;11:1923\u201333.","journal-title":"Curr Biol"},{"key":"1966_CR7","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1073\/pnas.96.11.6125","volume":"96","author":"AG Eldridge","year":"1999","unstructured":"Eldridge AG, Li Y, Sharp PA, Blencowe BJ. The SRm160\/300 splicing coactivator is required for exon-enhancer function. Proc Natl Acad Sci USA. 1999;96:6125\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1966_CR8","doi-asserted-by":"publisher","first-page":"42227","DOI":"10.1074\/jbc.M507410200","volume":"280","author":"S McCracken","year":"2005","unstructured":"McCracken S, Longman D, Marcon E, Moens P, Downey M, Nickerson JA, et al. Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. J Biol Chem. 2005;280:42227\u201336.","journal-title":"J Biol Chem"},{"key":"1966_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1128\/MCB.22.1.148-160.2002","volume":"22","author":"S McCracken","year":"2002","unstructured":"McCracken S, Lambermon M, Blencowe BJ. SRm160 splicing coactivator promotes transcript 3\u2032-end cleavage. Mol Cell Biol. 2002;22:148\u201360.","journal-title":"Mol Cell Biol"},{"key":"1966_CR10","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.1093\/emboj\/19.24.6860","volume":"19","author":"H Le Hir","year":"2000","unstructured":"Le Hir H. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 2000;19:6860\u20139.","journal-title":"EMBO J"},{"key":"1966_CR11","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1093\/emboj\/20.17.4987","volume":"20","author":"H Le Hir","year":"2001","unstructured":"Le Hir H. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 2001;20:4987\u201397.","journal-title":"EMBO J"},{"key":"1966_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101954","volume":"79","author":"X Song","year":"2022","unstructured":"Song X, Ma J. SRRM1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the JAK\/STAT signaling pathway. Tissue Cell. 2022;79:101954.","journal-title":"Tissue Cell"},{"key":"1966_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.008","volume":"51","author":"JM Jimenez-Vacas","year":"2020","unstructured":"Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, G\u00f3mez-G\u00f3mez E, Fuentes-Fayos AC, Le\u00f3n-Gonz\u00e1lez AJ, et al. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine. 2020;51:102547.","journal-title":"EBioMedicine"},{"key":"1966_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/MCB.26.1.362-370.2006","volume":"26","author":"C Cheng","year":"2006","unstructured":"Cheng C, Sharp PA. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol. 2006;26:362\u201370.","journal-title":"Mol Cell Biol"},{"key":"1966_CR15","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/humu.22844","volume":"36","author":"N Sobreira","year":"2015","unstructured":"Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928\u201330.","journal-title":"Hum Mutat"},{"key":"1966_CR16","doi-asserted-by":"crossref","unstructured":"Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, et al. Influence of LOX\/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines. Int J Mol Med. 2009;25:271\u201380.","DOI":"10.3892\/ijmm_00000341"},{"key":"1966_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19441-8","volume":"8","author":"MF Sentmanat","year":"2018","unstructured":"Sentmanat MF, Peters ST, Florian CP, Connelly JP, Pruett-Miller SM. A survey of validation strategies for CRISPR-Cas9 editing. Sci Rep. 2018;8:888.","journal-title":"Sci Rep"},{"key":"1966_CR18","doi-asserted-by":"publisher","unstructured":"Baecker V. ImageJ macro tool sets for biological image analysis. In: Proceedings of the ImageJ User and Developer Conference. Luxembourg; 2012. https:\/\/doi.org\/10.13140\/RG.2.1.2868.9446.","DOI":"10.13140\/RG.2.1.2868.9446"},{"key":"1966_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-357","volume":"12","author":"Y Hu","year":"2011","unstructured":"Hu Y, Flockhart I, Vinayagam A, Bergwitz C, Berger B, Perrimon N, et al. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinforma. 2011;12:357.","journal-title":"BMC Bioinforma"},{"key":"1966_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1242\/dev.118.2.401","volume":"118","author":"AH Brand","year":"1993","unstructured":"Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401\u201315.","journal-title":"Development"},{"key":"1966_CR21","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/ng.3664","volume":"48","author":"RGH Lindeboom","year":"2016","unstructured":"Lindeboom RGH, Supek F, Lehner B. The rules and impact of nonsense-mediated mRNA decay in human cancers. Nat Genet. 2016;48:1112\u20138.","journal-title":"Nat Genet"},{"key":"1966_CR22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","volume":"51","author":"RGH Lindeboom","year":"2019","unstructured":"Lindeboom RGH, Vermeulen M, Lehner B, Supek F. The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nat Genet. 2019;51:1645\u201351.","journal-title":"Nat Genet"},{"key":"1966_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100.","journal-title":"Nature"},{"key":"1966_CR24","doi-asserted-by":"crossref","unstructured":"Wiel L, Baakman C, Gilissen D, Veltman JA, Vriend G, Gilissen C. MetaDome: pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Human Mutation. 2019; https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.23798.","DOI":"10.1002\/humu.23798"},{"key":"1966_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajhg.2015.11.024","volume":"98","author":"K Kochinke","year":"2016","unstructured":"Kochinke K, Zweier C, Nijhof B, Fenckova M, Cizek P, Honti F, et al. Systematic phenomics analysis deconvolutes genes mutated in intellectual disability into biologically coherent modules. Am J Hum Genet. 2016;98:149\u201364.","journal-title":"Am J Hum Genet"},{"key":"1966_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ajhg.2009.03.010","volume":"84","author":"HV Firth","year":"2009","unstructured":"Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet. 2009;84:524\u201333.","journal-title":"Am J Hum Genet"},{"key":"1966_CR27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.celrep.2019.03.072","volume":"27","author":"Y Nakano","year":"2019","unstructured":"Nakano Y, Wiechert S, B\u00e1nfi B. Overlapping activities of two neuronal splicing factors switch the GABA effect from excitatory to inhibitory by regulating REST. Cell Rep. 2019;27:860\u201371.e8.","journal-title":"Cell Rep"},{"key":"1966_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1101\/gad.256115.114","volume":"29","author":"M Quesnel-Vallieres","year":"2015","unstructured":"Quesnel-Vallieres M, Irimia M, Cordes SP, Blencowe BJ. Essential roles for the splicing regulator nSR100\/SRRM4 during nervous system development. Genes Dev. 2015;29:746\u201359.","journal-title":"Genes Dev"},{"key":"1966_CR29","doi-asserted-by":"publisher","DOI":"10.1242\/bio.060415","volume":"13","author":"S Carvalho","year":"2024","unstructured":"Carvalho S, Zea-Redondo L, Tang TCC, Stachel-Braum P, Miller D, Caldas P, et al. SRRM2 splicing factor modulates cell fate in early development. Biol Open. 2024;13:bio060415.","journal-title":"Biol Open"},{"key":"1966_CR30","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.gim.2022.04.011","volume":"24","author":"S Cuinat","year":"2022","unstructured":"Cuinat S, Nizon M, Isidor B, Stegmann A, van Jaarsveld RH, van Gassen KL, et al. Loss-of-function variants in SRRM2 cause a neurodevelopmental disorder. Genet Med. 2022;24:1774\u201380.","journal-title":"Genet Med"},{"key":"1966_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ajhg.2020.06.019","volume":"107","author":"A Fliedner","year":"2020","unstructured":"Fliedner A, Kirchner P, Wiesener A, van de Beek I, Waisfisz Q, van Haelst M, et al. Variants in SCAF4 cause a neurodevelopmental disorder and are associated with impaired mRNA processing. Am J Hum Genet. 2020;107:544\u201354.","journal-title":"Am J Hum Genet"},{"key":"1966_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171235","volume":"134","author":"D Li","year":"2024","unstructured":"Li D, Wang Q, Bayat A, Battig MR, Zhou Y, Bosch DGM, et al. Spliceosome malfunction causes neurodevelopmental disorders with overlapping features. J Clin Investig. 2024;134:e171235.","journal-title":"J Clin Investig"},{"key":"1966_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39040-0","volume":"14","author":"KL Ayers","year":"2023","unstructured":"Ayers KL, Eggers S, Rollo BN, Smith KR, Davidson NM, Siddall NA, et al. Variants in SART3 cause a spliceosomopathy characterised by failure of testis development and neuronal defects. Nat Commun. 2023;14:3403.","journal-title":"Nat Commun"},{"key":"1966_CR34","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41586-024-07773-7","volume":"632","author":"Y Chen","year":"2024","unstructured":"Chen Y, Dawes R, Kim HC, Ljungdahl A, Stenton SL, Walker S, et al. De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome. Nature. 2024;632:832\u201340.","journal-title":"Nature"},{"key":"1966_CR35","doi-asserted-by":"crossref","unstructured":"Greene D, Thys C, Berry IR, Jarvis J, Ortibus E, Mumford AD, et al. Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders. Nat Med. 2024;30:2165\u20139.","DOI":"10.1038\/s41591-024-03085-5"},{"key":"1966_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22627-w","volume":"12","author":"S Kour","year":"2021","unstructured":"Kour S, Rajan DS, Fortuna TR, Anderson EN, Ward C, Lee Y, et al. Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder. Nat Commun. 2021;12:2558.","journal-title":"Nat Commun"},{"key":"1966_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75999-2","volume":"10","author":"A Fliedner","year":"2020","unstructured":"Fliedner A, Gregor A, Ferrazzi F, Ekici AB, Sticht H, Zweier C. Loss of PHF6 leads to aberrant development of human neuron-like cells. Sci Rep. 2020;10:19030.","journal-title":"Sci Rep"},{"key":"1966_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fcell.2019.00205","volume":"7","author":"YH Pan","year":"2019","unstructured":"Pan YH, Wu N, Yuan XB. Toward a better understanding of neuronal migration deficits in autism spectrum disorders. Front Cell Dev Biol. 2019;7:205.","journal-title":"Front Cell Dev Biol"},{"key":"1966_CR39","doi-asserted-by":"publisher","first-page":"ENEURO.0238-16.","DOI":"10.1523\/ENEURO.0238-16.2016","volume":"3","author":"J Gilbert","year":"2016","unstructured":"Gilbert J, Man HY. The X-linked autism protein KIAA2022\/KIDLIA regulates neurite outgrowth via N-Cadherin and \u03b4-catenin signaling. eNeuro. 2016;3:ENEURO.0238-16.2016.","journal-title":"eNeuro"},{"key":"1966_CR40","unstructured":"The UniProt Consortium, Bateman A, Martin MJ, Orchard S, Magrane M, Adesina A, et al. UniProt: the universal protein knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609\u201317."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01966-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01966-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01966-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:45:59Z","timestamp":1769769959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01966-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1966"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01966-y","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Department of Molecular and Human Genetics at Baylor College of Medicine receives revenue from clinical genetic testing completed at Baylor Genetics Laboratories (JAR). The other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Testing in a standard diagnostic setting did not require an ethic approval. Testing in a research setting was performed under ethical approval of the respective institutional review boards (e.g. UDN Institutional Review Board). The research protocol fulfilled the requirements of the local institutional ethics committee (Kantonale Ethikkommission Bern, 2021-01396). Consent for publication of genetic and clinical data, as well as photographs was obtained from the individuals\u2019 parents or legal guardians. The study complied with the principles set out in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}